Stay updated on Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial
Sign up to get notified when there's something new on the Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial page.

Latest updates to the Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedUpdated core page content to reflect a version bump to v3.2.0 and a government-status notice; removed the prior v3.1.0 version reference.SummaryDifference4%
- Check22 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%
- Check30 days agoNo Change Detected
- Check37 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the old Back to Top element was removed.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check51 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with additional drug information related to Lisdexamfetamine Dimesylate and various related topics. The previous version's drug information and related topics have been significantly reduced.SummaryDifference5%
- Check65 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
Stay in the know with updates to Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intravenous NRP104 Safety in Stimulant Abuse Clinical Trial page.